U.S. to remove mercury preservative from flu shots following RFK Jr. vaccine panel vote 

U.S. to remove mercury preservative from flu shots following RFK Jr. vaccine panel vote 


U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., speaks with Agriculture Secretary Brooke Rollins and Senator Roger Marshall (R-KS) ahead of a roundtable event as part of the “Make America Healthy Again” (MAHA) agenda, on Capitol Hill in Washington, D.C., U.S., July 15, 2025.

Ken Cedeno | Reuters

The Department of Health and Human Services on Wednesday said it will officially remove the mercury-based preservative thimerosal from all flu shots distributed in the U.S. – even though there is no evidence of harm from the ingredient. 

While few jabs still contain thimerosal, the move eliminates a vaccine option for Americans and is a win for the anti-vaccine movement, which has long targeted the ingredient.

HHS Secretary Robert F. Kennedy Jr. formally adopted a June recommendation from a key government vaccine panel, called the Advisory Committee on Immunization Practices, or ACIP, against influenza shots containing thimerosal. Earlier that month, Kennedy gutted that panel and restacked it with new members, including some widely known anti-vaccine activists. 

The decision affects roughly 4% to 5% of the U.S. flu vaccine supply. That includes some multi-dose forms of Sanofi‘s Fluzone and two shots from biotech company CSL Seqirus. The rest of the nation’s flu shots were thimerosal-free during the last season of the virus, according to CDC data.

Vaccine manufacturers have confirmed that they have the capacity to replace multi-dose vials containing mercury, HHS said. That will ensure that the flu vaccine for adults and a government program that provides shots to uninsured and underinsured children won’t be interrupted, the agency added. 

Still, health experts have said that eliminating thimerosal-containing flu shots as an option for Americans could lead to fewer people receiving jabs.

The move also reinforces longstanding, unfounded fears that the substance can lead to developmental disabilities, such as autism. Kennedy’s vaccine skepticism comes full circle with ACIP’s vote: A decade before stepping into his current role, he published a book that called for the removal of thimerosal from shots and linked it to developmental disorders.

“After more than two decades of delay, this action fulfills a long-overdue promise to protect our most vulnerable populations from unnecessary mercury exposure,” Kennedy said in a release, urging global health authorities to follow suit. 

More than 40 studies over several decades have found no link between thimerosal and developmental delays. Thimerosal has been widely used for decades as a preservative to prevent the growth of harmful bacteria in several medicines and vaccines with multiple doses.

HHS said other recommendations from the panel’s meeting in June are still under review.



Source

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity
Health

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity

For the first time in decades, people are having real conversations about health care, “from the ground up,” says Dr. Toyin Ajayi. That has her feeling optimistic. “We’re in a moment where health and health care — and what it means to be healthy — is the subject of a national discussion,” the co-founder and […]

Read More
Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq
Health

Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq

Methodiq brand advertisement. Courtesy: Methodiq Il Makiage parent company Oddity is branching out into medical-grade skin care with its new brand Methodiq, as the online retailer looks to compete with Hims and help to address what it called a “broken medical care system.”  Methodiq, which has been in the works for four years and launched […]

Read More
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to 9 a month
Health

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump administration to […]

Read More